A drug delivery system of lipid-coated hollow mesoporous silica nanoparticles for curcumin(CUR-HMSN@lip) was constructed. Its formulation and process parameters were optimized, and its pharmacokinetic behavior in rats was investigated. The obtained CUR-HMSN@lip was characterized by TEM, PXRD, ζ potential, and thermogravimetric analyses, and the results indicated that the curcumin-loaded hollow mesoporous silica nanoparticles(CUR-HMSN) were successfully encapsulated by phospholipids. After orally administered of CUR-HMSN@lip to rats, the pharmacokinetic parameters of curcumin were determined and calculated. The results were as follows: tmax was (1.83±0.41)h, AUClast was (570.82±48.07)h·ng·mL–1, and MRTlast was (5.68±1.21)h. Compared with the CUR-HMSN treatment group, the plasma concentration-time curve of the CUR-HMSN@lip treatment group did not show a double peak phenomenon. The relative bioavailability of CUR-HMSN@lip was 203.8%. It was concluded that the CUR-HMSN@lip delivery system increased the bioavailability of curcumin and improved the burst release of CUR-HMSN.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |